Next Article in Journal
The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver
Next Article in Special Issue
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
Previous Article in Journal
Identification of Novel Adenylyl Cyclase 5 (AC5) Signaling Networks in D1 and D2 Medium Spiny Neurons using Bimolecular Fluorescence Complementation Screening
Previous Article in Special Issue
Dynamic Interplay between Pericytes and Endothelial Cells during Sprouting Angiogenesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study

1
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
2
Division of Colon and Rectal Surgery, Department of Surgery, Chiayi Chang Gung Memorial Hospital, Chiayi County 613, Taiwan
3
Department of Urology, College of Medicine, National Taiwan University, and National Taiwan University Hospital, Taipei 100, Taiwan
4
Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
5
Department of Pathology, College of Medicine, National Taiwan University, and National Taiwan University Hospital, Taipei 100, Taiwan
6
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 106, Taiwan
7
Department of Urology, Taipei City Hospital Heping Fuyou Branch, Taipei 100, Taiwan
*
Author to whom correspondence should be addressed.
Cells 2019, 8(11), 1469; https://doi.org/10.3390/cells8111469
Submission received: 14 September 2019 / Revised: 28 October 2019 / Accepted: 14 November 2019 / Published: 19 November 2019
(This article belongs to the Special Issue Angiogenesis in Cancer)

Abstract

Cancer cells rely on aberrant transcription for growth and survival. Cyclin-dependent kinases (CDKs) play critical roles in regulating gene transcription by modulating the activity of RNA polymerase II (RNAPII). THZ1, a selective covalent inhibitor of CDK7, has antitumor effects in several human cancers. In this study, we investigated the role and therapeutic potential of CDK7 in regulating the angiogenic activity of endothelial cells and human renal cell carcinoma (RCC). Our results revealed that vascular endothelial growth factor (VEGF), a critical activator of angiogenesis, upregulated the expression of CDK7 and RNAPII, and the phosphorylation of RNAPII at serine 5 and 7 in human umbilical vein endothelial cells (HUVECs), indicating the transcriptional activity of CDK7 may be involved in VEGF-activated angiogenic activity of endothelium. Furthermore, through suppressing CDK7 activity, THZ1 suppressed VEGF-activated proliferation and migration, as well as enhanced apoptosis of HUVECs. Moreover, THZ1 inhibited VEGF-activated capillary tube formation and CDK7 knockdown consistently diminished tube formation in HUVECs. Additionally, THZ1 reduced VEGF expression in human RCC cells (786-O and Caki-2), and THZ1 treatment inhibited tumor growth, vascularity, and angiogenic marker (CD31) expression in RCC xenografts. Our results demonstrated that CDK7-mediated transcription was involved in the angiogenic activity of endothelium and human RCC. THZ1 suppressed VEGF-mediated VEGFR2 downstream activation of angiogenesis, providing a new perspective for antitumor therapy in RCC patients.
Keywords: THZ1; cyclin-dependent kinase 7; angiogenesis; endothelial cell; renal cell carcinoma THZ1; cyclin-dependent kinase 7; angiogenesis; endothelial cell; renal cell carcinoma

Share and Cite

MDPI and ACS Style

Shi, C.-S.; Kuo, K.-L.; Chen, M.-S.; Chow, P.-M.; Liu, S.-H.; Chang, Y.-W.; Lin, W.-C.; Liao, S.-M.; Hsu, C.-H.; Hsu, F.-S.; et al. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study. Cells 2019, 8, 1469. https://doi.org/10.3390/cells8111469

AMA Style

Shi C-S, Kuo K-L, Chen M-S, Chow P-M, Liu S-H, Chang Y-W, Lin W-C, Liao S-M, Hsu C-H, Hsu F-S, et al. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study. Cells. 2019; 8(11):1469. https://doi.org/10.3390/cells8111469

Chicago/Turabian Style

Shi, Chung-Sheng, Kuan-Lin Kuo, Mei-Sin Chen, Po-Ming Chow, Shing-Hwa Liu, Yu-Wei Chang, Wei-Chou Lin, Shih-Ming Liao, Chen-Hsun Hsu, Fu-Shun Hsu, and et al. 2019. "Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study" Cells 8, no. 11: 1469. https://doi.org/10.3390/cells8111469

APA Style

Shi, C.-S., Kuo, K.-L., Chen, M.-S., Chow, P.-M., Liu, S.-H., Chang, Y.-W., Lin, W.-C., Liao, S.-M., Hsu, C.-H., Hsu, F.-S., Chang, H.-C., & Huang, K.-H. (2019). Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study. Cells, 8(11), 1469. https://doi.org/10.3390/cells8111469

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop